(Q53345492)
Statements
An open-label dose escalation study of the nitric oxide synthase inhibitor, N(G)-methyl-L-arginine hydrochloride (546C88), in patients with septic shock. Glaxo Wellcome International Septic Shock Study Group (English)
R Grover
D Zaccardelli
G Colice
K Guntupalli